Foresite Capital, which is a venture capital firm that specializes in healthcare, recently announced the appointment of Dr. Molly He, Ph.D. as the new venture partner. Dr. He worked as a senior director of Illumina before joining Foresite Capital. Her 15 years’ experience in the genomic and pharmaceutical research and development will be appreciated in Foresite Capital.
Dr. Jim Tananbaum, who is the Chief Executive Officer of Foresite Capital couldn’t conceal his delight in having Dr. He on board. He mentioned her contribution to the scientific research as remarkable and her leadership track record as among her strong suits. He stated that Dr. He’s contribution would come in handy as Foresite Capital continues to expand their portfolio of transformational companies.
Dr. He is credited for helping Illumina to innovate and improve its global protein reagent. Her experience in developing protein reagent also allowed her to work at Pacific Biosciences, where she served as the head of protein sciences. She helped Pacific Biosciences to develop their protein reagent for their “single molecular real-time sequencing chemistry” and learn more about Jim.
She has over ten years’ experience in the pharmaceutical industry where she spent most of her time designing and developing antibodies that target immune diseases and cancer. She attended the Nankai University, where she graduated with a Bachelor’s degree in Biochemistry. She also attended the University of California, where she graduated with a Ph.D. in Protein Biophysics. She has written more than twenty papers and holds over twenty patents in personal medicine and next-generation sequencing and more information click here.
Jim Tananbaum is the founder and CEO of Foresite Capital Management, a venture capital firm that specializes in healthcare.
Jim attended the Yale University, where he graduated with a Bachelor of Science in Electrical Engineering in Math and Computer Science. Jim of Linkedin, He later joined MIT, where he graduated with a master of science in Information Theory. He is also a graduate of the Harvard University with a Doctor of Medicine Degree and holds an MBA from the Harvard Business School.
More visit: https://twitter.com/jtananbaum